Edinburgh IN 1847 Vogel established that cholesterol was present in atheromatous plaques. Virchow (1856) suggested that these plaques were partly due to the passage of blood from the arterial lumen into the vessel wall and to subsequent fatty deposition. Since Anitschkow and Chalatow (1913) first produced atheroma in rabbits, it has been known that various diets, rich in cholesterol, result in the development of fairly typical atheromatous lesions in many different species. Such diets lead to atheromatous lesions only when they cause elevation of the plasma cholesterol level and usually the severity of the lesions can be directly related to the degree and the duration of hypercholesterolemia. These observations have led to intensive study of the plasma lipids in patients with atherosclerosis.
Plasma Lipids
The principal plasma lipids are triglycerides or neutral fats (which can aggregate to form chylomicra), cholesterol and phospholipids. Triglycerides, most of the plasma cholesterol and all phospholipids are esterified with various fatty acids. The concentration of plasma triglycerides depends largely on the phase of intestinal absorption of fat, but the plasma cholesterol and phospholipid levels are independent of fat absorption. These lipids are transported in plasma combined with one another and with protein in macromolecular or lipoprotein complexes, some properties of which have recently been reviewed (Boyd and Oliver, 1958) . These complexes can be fractionated according to certain chemical and physical characteristics into beta-lipoproteins (low density, or 111-0 fraction) and alpha-lipoproteins (high density, or IV-I fraction).
The plasma lipids currently estimated in investigations into atherosclerosis are triglycerides and chylomicra, total (esterified and unesterified) cholesterol, phospholipids, alpha-and beta-lipoproteins and their subdivisions and, more recently, the fatty acid composition of plasma and of ester cholesterol. In general, elevation of plasma cholesterol is associated with elevation of beta-lipoprotein cholesterol and often with reduction of alpha-lipoprotein cholesterol, and reduction of plasma cholesterol with the converse lipoprotein pattern. Since these are interdependent variables, it is permissible to simplify this discussion by considering particularly the concentration of total cholesterol in plasma in health and in relation to atherosclerosis.
Plasma Lipids in Health
In health the plasma cholesterol level is not constant but may fluctuate, for reasons largely unexplained, by as much as 20% (Levere et al., 1958) . In newborn infants the level is low but rises rapidly within the first ten days and thereafter gradually until puberty (Sperry, 1936) . In men plasma cholesterol continues to rise slightly until about the middle thirties after which it remains fairly constant (Adlersberg et al., 1956) . In women there is a regular cyclical change with each menstrual cycle and plasma cholesterol may be 20% lower at the time of ovulation than during the preceding and succeeding weeks (Oliver and Boyd, 1953a) . There is also a significant rise during the decade after the menopause (Oliver and Boyd, 1959a) . The plasma cholesterol level also varies according to race, but it is difficult to dissociate primary racial influences from dietetic habits (Keys, 1956) , and it is probable that racial differences are largely a function of nutrition which itself has an important effect.
All these factors which influence plasma lipid levels in health are important when assessing changes in lipid levels in relation to atherosclerosis.
Plasma Lipids in Coronary Heart Disease
Certain plasma lipids are often abnormal in patients with coronary heart disease. The plasma cholesterol and to a lesser extent the plasma phospholipids are both elevated; thus in many patients the cholesterol/phospholipid (C/P) ratio is also elevated (Gertler et al., 1950; Steiner et al., 1952; Oliver and Boyd, 1953b) . The beta-lipoprotein cholesterol and certain lowdensity lipoproteins are frequently elevated (Barr et al., 1951; Jones et al., 1951; Nikkila, 1953; Oliver and Boyd, 1955; Smith, 1957; Dodds and Mills, 1959) . These abnormalities are not present in all cases but are more marked and more frequent in those under 50 years than in older patients. Dodds and Mills (1959) have clearly shown that significant changes also occur in the plasma lipoproteins during the first two months after an acute myocardial infarct.
After a meal additional fat, almost entirely in the form of chylomicra, enters the blood stream from the thoracic duct and causes a transient increase in triglycerides and visible lipaemia. In patients with coronary heart disease the duration of this postprandial lipaemia is longer than in healthy subjects (Becker et al., J949; Barritt,  Proceedings of the Royal Society of Medicine 1956), and near its peak it is less readily cleared by heparin (Block et al., 1951; Oliver and Boyd, 1953c) . Evidence that such persistence of chylomicra may favour blood coagulation has been fully reviewed by Poole (1958) . Because coronary atherosclerosis has in part been attributed to a dietetic deficiency of essential unsaturated fatty acids (Sinclair, 1956) , measurements have been made of the plasma fatty acid composition in patients with coronary heart disease. Although Antonis (1957) reported a lower percentage of dienoic acids in coronary patients than in normal subjects, James et al. (1957) , using gas liquid chromatography, could detect no significant abnormality in the fatty acid composition of serum. Whereas Lewis (1958) found a significantly lower percentage of linoleic and arachidonic acids in plasma ester cholesterol in coronary patients, Wright et al. (1959) did not find any difference in the essential fatty acid content of cholesterol esters of atheromatous tissue and of healthy aortas. Employing chromatographic separation of cholesterol esters by silicic acid columns, we have observed no difference in the fatty acids of ester cholesterol in patients with coronary disease and in healthy men, and the only significant finding is that the fatty acids appear less saturated in young women than in young men. More studies of fatty acid compositions are clearly required.
No definite abnormality of the plasma lipids has been established in patients presenting with cerebral or peripheral vascular disease. Many such patients have co-existing coronary atherosclerosis, often of an advanced degree, and any attempt to differentiate patients with atherosclerosis in one vascular system from those with atherosclerosis in another is likely to be misleading. Our investigations have indicated that the plasma lipid pattern in patients with predominant cerebral or peripheral vascular disease has the same trend as in coronary patients but is less abnormal.
Etiological significance of abnormal plasma lipids.-The positive relationship between hypercholesterolbmia and the development of atheromatous lesions, established in many animals, probably also applies in man. Epidemiological studies in the United States indicate that there is an increased risk of coronary heart disease in individuals with antecedent elevation of plasma cholesterol (Dawber et al., 1957; Doyle et al., 1957) . Familial hypercholesterolaemia, whether xanthomatosis is present or not, is also associated with increased susceptibility to coronary heart disease (Epstein et al., 1959) . Furthermore, the Co-operative Study of Lipoproteins (1956) has indicated that elevation of plasma cholesterol precedes the development of coronary heart disease and is not merely associated with the onset of clinical features. There would seem to be four possible explanations for this association of coronary heart disease with a disturbance of plasma lipids.
(1) It might be a chance association, but this can be dismissed with reasonable confidence since many comprehensive inve'stigations have indicated that a significant association exists.
(2) It is conceivable that a primary change within the wall of the coronary arteries could result in a disturbance of the plasma lipids. The arterial wall is capable of synthesizing cholesterol, and Werthessen et al. (1954) have suggested that in growing animals the arterial wall may supply cholesterol to the plasma. Since the liver is the most active organ in synthesizing cholesterol and arterial cholesterol biosynthesis decreases with age, this source of plasma cholesterol is probably not very important in relation to atherosclerosis. Nor is it likely that some primary mural lesion, such as capillary hemorrhage or degenerative processes which may both be associated with accumulation of cholesterol esters, is capable of influencing the plasma lipids significantly. Moreover the quantity of lipid in atherosclerotic lesions is so large that it cannot all originate from the breakdown of arterial tissue (Duff and McMillan, 1951) .
(3) Elevated plasma lipids may contribute directly towards the development of coronary atheroma. This is widely believed to be one etiological factor, and the lipid composition of atherosclerotic plaques and of plasma is sufficiently similar to suggest that the lipids of the plaque are derived at least in part from the plasma. Isotope studies indicate that plasma cholesterol can be incorporated into atherosclerotic plaques in man.
(4) The association of abnormal plasma lipids and coronary heart disease might be secondary to other disturbances of physiological function. For example, deposition of fibrin on the arterial intima could act as a selective filter preventing the passage through the arterial wall of large lipoprotein molecules from the lumen and lead to disturbance of the plasma lipids. However, most of the exchanges between plasma and interstitial fluid which involve ultra-filtration and reabsorption of plasma components occur in the capillary bed, which is comparatively free from atherosclerosis. Another possibility is that alteration in the normal endocrine balance could lead to a disturbance of plasma lipids, of blood coagulation and fibrinolysis, of connective tissue and arteriolar permeability and thus to the development of atheroma (Oliver and Boyd, 1958) .
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Diagnostic significance of abnormal plasma lipids.-The diagnosis of coronary heart disease is, of course, based on clinical and electrocardiographic assessment and not on the finding of abnormal plasma lipids. The normal range of plasma lipids is wide and the abnormalities in coronary heart disease are slight. It is therefore seldom possible to attach diagnostic significance to an individual lipid pattern.
On the other hand, gross hypercholesterolkmia is probably a significant finding in a patient with equivocal clinical features. Most young males with coronary heart disease have abnormal plasma lipid levels. The percentage of coronary patients with "normal" values and the percentage of healthy subjects with elevated values are shown in Tables 1 and II. Under the age of 40, value for plasma cholesterol, cholesterol/ phospholipid ratio, or alpha/beta lipoprotein ratio (Oliver, 1958) . These particular values are only valid for the method and community under study, but do indicate that a-normal plasma lipid pattern is seldom present'in men who develop coronary heart disease in their thirties or early forties. Therapeutic implications of abnormal plasma lipids.-Since hypercholesterolemia is associated with an increased incidence of coronary heart disease, it is probably desitable to lower elevated plasma cholesterol levels, particularly in young subjects. As yet there is no convincing evidence that this has improved the prognosis, and preliminary observations suggest that the mortality from myocardial infarction has not been significantly improved by lowering plasma cholesterol (Oliver and Boyd, 1959b; Stamler et al., 1959) . This evidence is lacking largely because there have been insufficient and inadequately controlled studies of the effect of reduction of plasma cholesterol on prognosis. The rarity of atherosclerosis in concentration camp victims (Helweg-Larsen et al., 1952) suggests that even advanced lesions may be reversible, but it would be surprising if a reduction of plasma cholesterol alone could make much difference to a sclerosed, fibrotic and often calcified arterial wall or to a fibrosed and relatively ischmmic myocardium. Ideally, the benefit of lowering the plasma cholesterol level should be tested over a fiveor ten-year period in apparently healthy hypercholesterolemic young men. Summary
Although abnormal plasma lipid levels are found in many patients with coronary heart disease, the etiological significance of the association of hypercholesterolkmia with human atherosclerosis has not been explained. Plasma lipid abnormalities are most marked in young men with coronary artery disease and in such patients may be a useful adjuvant to a difficult clinical diagnosis; in older patients they have little diagnostic significance. The desirability of correcting abnormal plasma lipid levels has not yet been established.
The implication of such changes in experience of one racial group, is that environmental factors may be of major importance. In support of this is the experience of Yemenite Jews (Toor et al., 1957) immigrating to Israel. During the last 2,000 years, these people, wandering in the Arabian deserts or living in Ghetto conditions in Arabian towns, have by segregation remained a relatively "pure" race. Some have immigrated to Israel recently and others have been there for twenty years: the Israeli medical service is common to both. The relevant heart disease mortality rates in 1953-55 for the recent immigrants are 490 per million, compared with 3,300 per million for those who have been in Israel for twenty years (Table II) . This makes an interesting comparison with England and Wales, where the relevant rates were 490 deaths per million in 1931 and 3,590 in 1957. Epstein et al. (1957) were able to show a difference in prevalence of coronary heart disease in two groups of pecple similar in respect of many environmental factors believed to be importantbut differing in race. Jews born in the U.S.A. of European Jewish immigrants were compared with Italians born in the U.S.A. of Italian immigrants. They were similar in sex and age; in the same occupation; similar in body-build, the frequency of overweight and in the total fat in their diet as expressed as a percentage of total calories; similar in the presence of factors known to be associated with coronary heart diseasee.g. hypertension, xanthelasma, diabetes mellitus. They had the same prevalence of previously undetected coronary heart disease. These Jews and Italians did differ a little in mean serum cholesterol and in the percentage of animal fat in their diet. However, they differed markedly in the incidence of overt coronary heart disease. The Jews had two to three times as much coronary heart disease as the Italians; and this difference was similar for comparisons of coronary heart disease in various sub-groups, e.g. in the men with low cholesterol, low weight and low blood pressure; in the retired group; and in those dying of an acute "coronary attack" (Table III) . The Jewish garment workers also had far more peripheral vascular disease. This is not conclusive evidence of a genetic factor, of course; but environment seemed to differ little. It might be argued that there was a
